Gitnux/Report 2026

AI Symptom Checker Industry Statistics

The global symptom checker chatbots market reached $1.44 billion in 2025, explore the figures behind growth, company scale, and adoption trends through 2026.
4Statistics
24Sources
2Sections
1Visuals
12mRead
AI Symptom Checker Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The AI symptom checker industry at a glance

The AI symptom checker chatbot market reached $1.44 billion in 2025 and is expanding rapidly as healthcare providers, payers and consumers adopt automated symptom assessment and triage.

$1.44B[4]
Market size, 2025
24.9%[4]
Growth rate, 2025–2026
35M[5]
Ada assessments completed
56.43%[6]
U.S. traffic share, June 2026
Market size
The global symptom checker chatbots market was valued at $1.44 billion in 2025 and is projected to reach $1.8 billion in 2026. The estimate covers revenues from symptom analysis, healthcare assistance, data collection and healthcare-system integration.[4]
Forecast & CAGR
The market is forecast to grow at a 24.9% compound annual growth rate from 2025 to 2026. Growth is attributed to digital-health adoption, mobile applications, healthcare-access needs, clinician shortages and generative-AI investment.[4]
Market share & regions
North America was the largest regional market in 2025. Separately, the United States accounted for 56.43% of tracked AI symptom-checker website traffic in June 2026, while the United Kingdom and Canada accounted for 4.53% and 3.71%, respectively.[4][6]
Segmentation
The industry is segmented by technology into rule-based, hybrid and artificial-intelligence-based systems; by deployment into web-based and app-based products; and by end user into consumers or patients, healthcare providers, and insurers or other healthcare payers.[4]
Key players & concentration
Named providers include Ada Health, Babylon Health, WebMD, K Health, Infermedica, Buoy Health, HealthTap, Healthily, Mediktor, Ubie, Clearstep, Isabel Healthcare and Symptomate. Public market-share data are not sufficiently disclosed to calculate a reliable concentration ratio.[4]
Pricing
Consumer access is commonly free: Ada advertises a free symptom checker. Enterprise offerings are sold through client-branded integrations and health-plan partnerships, but publicly comparable subscription or contract prices were not identified.[7][5]
Trends, drivers & challenges
Key drivers include healthcare-access shortages, chronic-condition management, mobile-health adoption and generative-AI development. Main challenges are variable accuracy, bias, limited transparency and the risk that users may treat automated guidance as a medical diagnosis; a 2026 audit evaluated three platforms and cautioned that findings from those platforms cannot be generalized to the whole category.[4][3][8]
Consumer behavior & competition
Ada reports 35 million completed assessments worldwide, while its public app page reports 15 million users and seven product languages. Competition spans consumer apps, provider-integrated triage tools and general-purpose AI assistants, with differentiation increasingly based on clinical evidence, care navigation, integrations and language coverage.[5][7][9]
M&A
CB Insights recorded several notable 2024 transactions and investments: Fabric acquired GYANT on January 31, 2024, Mediktor acquired Sensely on June 4, 2024, and Ubie completed Series D financing rounds in April and October 2024. No more recent comparable transaction dataset was identified.[10]
Regulation
In January 2026, the FDA issued final guidance clarifying which clinical decision-support software functions may be excluded from the device definition and confirming that device functions intended for patients or caregivers remain subject to applicable digital-health policies. In August 2025, FDA also finalized guidance on predetermined change-control plans for AI-enabled device software.[11]
Latest news
The most recent industry-relevant evidence includes a March 2026 audit of Ada, Isabel and Docus AI that examined sex-based diagnostic bias, and FDA’s January 2026 final clinical-decision-support guidance. These developments keep evaluation, transparency and patient safety central to commercial deployment.[3][11]

02 Ranking

Top 10 Companies in the AI Symptom Checker Industry

The leading companies in the AI symptom checker industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Ada Health stands out for AI symptom assessment because Ada reports 35 million completed assessments, while Fabric is the pick for AI symptom triage since its GYANT technology includes an AI-enhanced symptom checker for adult and pediatric triage.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in AI symptom triage

    Ada Health

    DE

    Ranked #1 · 9.7 · AI symptom triage

    Why we picked it: It supports evidence-focused symptom assessment at scale, with 35 million completed assessments reported.

  2. #2 overall

    Fabric

    US

    Ranked #2 · 9.2 · AI symptom triage

    Why we picked it: It targets triage workflows via GYANT, covering both adult and pediatric symptom checking.

  3. Leader in clinical decision-support

    XUND

    AT

    Ranked #4 · 8.4 · Clinical decision-support

    Why we picked it: It differentiates through MDR-certified symptom and illness checking products for patients and organizations.

Pick 1 is the #1 company overall. Pick 2 is the highest-ranked company in the top 5 that adds a new segment; no further segment places in the top 5, so pick 3 follows rank.

Full ranking

Sort by
Top 10 companies in the AI symptom checker industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Ada Health

AI symptom triage · DE

9.7
2

Fabric

AI symptom triage · US

9.2
3

Ubie

AI symptom triage · JP

9.0
4

XUND

Clinical decision-support · AT

8.4
5

Symptoma

AI symptom triage · AT

8.3
6

Infermedica

AI symptom triage and medical guidance platform · PL

8.2
7

Buoy Health

Consumer AI symptom checker and care guidance · US

8.2
8

Clearstep

AI symptom triage and care routing · US

8.2
9

Klinik Healthcare Solutions

AI patient access and symptom triage · GB

8.2
10

Mediktor

AI symptom assessment, triage and pre-diagnosis · ES

7.8

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the AI symptom checker industry. In AI Symptom Checker Industry Statistics. Gitnux. https://gitnux.org/ai-symptom-checker-industry-statistics/#top-companies

report visual · Comparison

Use status and future willingness for symptom checkers among insured German citizens (Germany)

Open to future use holds the largest share at 51%.

Open to future use51%
No use and not open to future use29%
Don't know11%
Already used9%
source-verifiedimage.marketing.deloitte.de

04 Statistics

Market Intelligence

The market estimate for 2025 covers symptom analysis, healthcare assistance, health-data collection, and healthcare-system integration. It explicitly includes AI-based systems as a segment.

Market size and revenue in the AI symptom checker industry

  • $1.44 billion was the global symptom-checker chatbots market size in 2025, covering revenues from healthcare assistance, symptom analysis and diagnosis, health-data collection, and healthcare-system integration; the study includes AI-based systems as a segment.[1]

05 Statistics

Operating Benchmarks

Benchmarks show diagnosis-list performance gaps in older evidence. In May 2019–April 2022, 24.2% and 45.1% of Japanese patients received a correct diagnosis within the top-10 differential list.

Operating metrics used in the AI symptom checker industry

  • 24.2% of 124 Japanese patients with uncommon diseases received a correct diagnosis within the AI symptom checker’s top-10 differential list during May 2019–April 2022; no newer measurement was identified.[2]
  • In a 2024 clinical-vignette study of six symptom checkers, the range between the best and worst products was 65.3 percentage points for M1 accuracy, where M1 means placing the main diagnosis first among 400 vignettes.[3]
  • 45.1% of 381 Japanese patients received a correct final diagnosis within the AI symptom checker’s top-10 differential list during May 2019–April 2022; no newer measurement was identified.[2]

Key questions about the AI symptom checker industry

What is the market size for AI symptom checker chatbots?
The global symptom checker chatbots market reached $1.44 billion in 2025. The estimate covers symptom analysis, healthcare assistance, data collection, and healthcare-system integration.
How fast is the market growing into 2026?
The market is projected to reach $1.8 billion in 2026. From 2025 to 2026, the forecast growth rate is 24.9%.
Which companies lead the AI symptom checker industry?
Ada Health stands out for AI symptom assessment because Ada reports 35 million completed assessments, while Fabric is the pick for AI symptom triage since its GYANT technology includes an AI-enhanced symptom checker for adult and pediatric triage.
How are technology approaches shifting across symptom checker systems?
The industry spans rule-based, hybrid, and artificial-intelligence-based systems. Industry activity also increasingly ties deployment to integration and healthcare-system workflows.
How concentrated is demand in geography based on website traffic?
In June 2026, the United States accounted for 56.43% of tracked AI symptom-checker website traffic. The United Kingdom and Canada accounted for 4.53% and 3.71%, respectively.
What evaluation or governance issues shape deployments in 2026?
Key challenges include variable accuracy, bias, limited transparency, and the risk users treat guidance as a medical diagnosis. A 2026 audit evaluated three platforms and cautioned that findings cannot be generalized to the whole category.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). AI Symptom Checker Industry Statistics. Gitnux. https://gitnux.org/ai-symptom-checker-industry-statistics
MLA
Samuel Norberg. "AI Symptom Checker Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/ai-symptom-checker-industry-statistics.
Chicago
Samuel Norberg. 2026. "AI Symptom Checker Industry Statistics." Gitnux. https://gitnux.org/ai-symptom-checker-industry-statistics.